The strongest predictors were the percentage of ER-positive cells (weight, 0.0395 ± 0.0237) and lymph node metastasis (weight: 0.0279 ± 0.0479). This evidence concerns the gene ESR1 and metastatic malignant neoplasm in the lymph nodes.